NEW YORK (GenomeWeb News) – Molecular diagnostics firm Xagenic today announced that it has closed a Series B round of financing that brought in $20 million (US$18.8 million) in funding.
Registering provides access to this and other free content.
Already have an account?Login Now.
PLOS Biology has asked researchers how they envision the future of genetics and genomics.
Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."
The US Food and Drug Administration has approved four molecularly targeted drugs this month, suggesting that personalized medicine has "turned a corner."
In Science this week: caution urged in use of gene drives, and more.